“In Russia, there is a sufficient supply of drugs based on ibuprofen, production does not stop, there are no risks of shortages.
This follows from the data of the Chestny Znak marking system, RIA Novosti reports.
According to the system, the production and import of drugs for the domestic market continues in sufficient volumes - 40 manufacturers and importers are involved in this.
Earlier it became known about the launch of the business transfer process in Russia by the British company Reckitt Benckiser, which owns such brands as Nurofen, Strepsils and Durex.